Immunicom recruits first patient in TNBC trial of Immunopheresis
Medical technology firm Immunicom has recruited first patient in multi-center and triple-negative breast cancer (TNBC) clinical trial of…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
Medical technology firm Immunicom has recruited first patient in multi-center and triple-negative breast cancer (TNBC) clinical trial of…
NanoVibronix, a medical device company, is developing a cannabidiol (CBD) patch and cream to make the CBD patch…
Synaptive Medical, a global pioneer in automation and robotics, today revealed an automated white matter segmentation feature to…